EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 315 filers reported holding EDITAS MEDICINE INC in Q4 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $129,000 | +25.2% | 3,143 | +72.5% | 0.01% | +40.0% |
Q2 2021 | $103,000 | +33.8% | 1,822 | -0.4% | 0.01% | +25.0% |
Q1 2021 | $77,000 | -54.7% | 1,830 | -70.0% | 0.00% | -63.6% |
Q3 2020 | $170,000 | – | 6,091 | +121720.0% | 0.01% | – |
Q2 2020 | $0 | -100.0% | 5 | -99.2% | 0.00% | -100.0% |
Q1 2020 | $13,000 | -23.5% | 653 | +11.1% | 0.00% | 0.0% |
Q4 2019 | $17,000 | +466.7% | 588 | +398.3% | 0.00% | – |
Q2 2019 | $3,000 | -76.9% | 118 | -79.3% | 0.00% | -100.0% |
Q4 2018 | $13,000 | -99.8% | 571 | +189.8% | 0.00% | 0.0% |
Q2 2018 | $7,058,000 | +176350.0% | 197 | +68.4% | 0.00% | – |
Q1 2018 | $4,000 | -50.0% | 117 | -58.7% | 0.00% | -100.0% |
Q4 2017 | $8,000 | +300.0% | 283 | +121.1% | 0.00% | – |
Q2 2017 | $2,000 | -50.0% | 128 | -31.6% | 0.00% | – |
Q1 2017 | $4,000 | -42.9% | 187 | -59.2% | 0.00% | -100.0% |
Q4 2016 | $7,000 | – | 458 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |